Search research articles
Contact Us
Filters
Showing results (51-60 of 63) with videos related to
Page
of 7
Sort By:
The Journal of Pathology
|
April 1, 2018
Somatic POLE exonuclease domain mutations are early events in sporadic endometrial and colorectal carcinogenesis, determining driver mutational landscape, clonal neoantigen burden and immune response
Daniel Temko, Inge C Van Gool, Emily Rayner, et al.
Journal of the National Cancer Institute
|
January 17, 2019
Pattern Recognition Receptor Polymorphisms as Predictors of Oxaliplatin Benefit in Colorectal Cancer
Victoria Gray, Sarah Briggs, Claire Palles, et al.
Cancer Immunology Research
|
March 16, 2019
A Transcriptionally Distinct CXCL13<sup>+</sup>CD103<sup>+</sup>CD8<sup>+</sup> T-cell Population Is Associated with B-cell Recruitment and Neoantigen Load in Human Cancer
Hagma H Workel, Joyce M Lubbers, Roland Arnold, et al.
Cancer Immunology Research
|
October 1, 2020
Prognostic Integrated Image-Based Immune and Molecular Profiling in Early-Stage Endometrial Cancer
Nanda Horeweg, Marco de Bruyn, Remi A Nout, et al.
Nature Communications
|
March 17, 2022
Tertiary lymphoid structures critical for prognosis in endometrial cancer patients
Nanda Horeweg, Hagma H Workel, Dominik Loiero, et al.
The Lancet. Oncology
|
February 1, 2024
Multiplex analysis of intratumoural immune infiltrate and prognosis in patients with stage II-III colorectal cancer from the SCOT and QUASAR 2 trials: a retrospective analysis
Anja L Frei, Anthony McGuigan, Ritik R A K Sinha, et al.
The Journal of Pathology. Clinical Research
|
September 12, 2023
Accounting for intensity variation in image analysis of large-scale multiplexed clinical trial datasets
Anja L Frei, Anthony McGuigan, Ritik Rak Sinha, et al.
The Lancet. Gastroenterology & Hepatology
|
July 26, 2018
Mutation burden and other molecular markers of prognosis in colorectal cancer treated with curative intent: results from the QUASAR 2 clinical trial and an Australian community-based series
Enric Domingo, Carme Camps, Pamela J Kaisaki, et al.
Nature Medicine
|
December 16, 2022
IL7 genetic variation and toxicity to immune checkpoint blockade in patients with melanoma
Chelsea A Taylor, Robert A Watson, Orion Tong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 8, 2026
ESR1 mutation in Endocrine treatment naive Endometrial Cancer: Prevalence, Characteristics and Prognostic Implications, results from the UTOLA phase II GINECO trial
Félix Blanc-Durand, Catherine Genestie, Sergey Nikolaev, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 63) with videos related to
Sort By:
Page
of 7
The Journal of Pathology
|
April 1, 2018
Somatic POLE exonuclease domain mutations are early events in sporadic endometrial and colorectal carcinogenesis, determining driver mutational landscape, clonal neoantigen burden and immune response
Daniel Temko, Inge C Van Gool, Emily Rayner, et al.
Journal of the National Cancer Institute
|
January 17, 2019
Pattern Recognition Receptor Polymorphisms as Predictors of Oxaliplatin Benefit in Colorectal Cancer
Victoria Gray, Sarah Briggs, Claire Palles, et al.
Cancer Immunology Research
|
March 16, 2019
A Transcriptionally Distinct CXCL13<sup>+</sup>CD103<sup>+</sup>CD8<sup>+</sup> T-cell Population Is Associated with B-cell Recruitment and Neoantigen Load in Human Cancer
Hagma H Workel, Joyce M Lubbers, Roland Arnold, et al.
Cancer Immunology Research
|
October 1, 2020
Prognostic Integrated Image-Based Immune and Molecular Profiling in Early-Stage Endometrial Cancer
Nanda Horeweg, Marco de Bruyn, Remi A Nout, et al.
Nature Communications
|
March 17, 2022
Tertiary lymphoid structures critical for prognosis in endometrial cancer patients
Nanda Horeweg, Hagma H Workel, Dominik Loiero, et al.
The Lancet. Oncology
|
February 1, 2024
Multiplex analysis of intratumoural immune infiltrate and prognosis in patients with stage II-III colorectal cancer from the SCOT and QUASAR 2 trials: a retrospective analysis
Anja L Frei, Anthony McGuigan, Ritik R A K Sinha, et al.
The Journal of Pathology. Clinical Research
|
September 12, 2023
Accounting for intensity variation in image analysis of large-scale multiplexed clinical trial datasets
Anja L Frei, Anthony McGuigan, Ritik Rak Sinha, et al.
The Lancet. Gastroenterology & Hepatology
|
July 26, 2018
Mutation burden and other molecular markers of prognosis in colorectal cancer treated with curative intent: results from the QUASAR 2 clinical trial and an Australian community-based series
Enric Domingo, Carme Camps, Pamela J Kaisaki, et al.
Nature Medicine
|
December 16, 2022
IL7 genetic variation and toxicity to immune checkpoint blockade in patients with melanoma
Chelsea A Taylor, Robert A Watson, Orion Tong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 8, 2026
ESR1 mutation in Endocrine treatment naive Endometrial Cancer: Prevalence, Characteristics and Prognostic Implications, results from the UTOLA phase II GINECO trial
Félix Blanc-Durand, Catherine Genestie, Sergey Nikolaev, et al.
Page
of 7